52 Million Children Suffering from Hepatitis

According to Polaris data, of 325 million confirmed patients worldwide, 52 million are minors, a number much higher than the 2.1 million children suffering from AIDS, according to recent statistics reported at the World Hepatitis Summit in Brazil. According to Raquel Peck, CEO of World Hepatitis Alliance, most infected infants and children are not diagnosed, prioritized, or treated effectively. Twenty-one countries are responsible for around 80% of pediatric hepatitis C infections, with the highest prevalence rates generally found in developing countries.  Of the 52 million, more than 90% have hepatit is B. However, the study showed that compared to hepatitis C, new hepatitis B infections among children are declining, from approximately 4.7% prevalence in the pre-vaccination era of the early 1980s to 1.3% in 2016. Data released at the summit indicated that 84% of countries offer Hepatitis B vaccines, but only 39% provide birth doses (Link 1, Link 2)....
Read More

JVH Supplement Published

Polaris Observatory publishes detailed country-level HCV data for 17 countries In November, the Journal of Viral Hepatitis published a supplement reporting hepatitis C virus epidemiology, modeling forecasts, and disease management strategies for 17 countries – Bahrain, Bulgaria, Cameroon, Colombia, Croatia, Dominican Republic, Ethiopia, Ghana, Hong Kong, Jordan, Kazakhstan, Malaysia, Morocco, Nigeria, Oman, Qatar, and Taiwan. This supplement contains analyses conducted by the Polaris Observatory staff in collaboration with more than 120 local experts. Considering the three supplements that came before this, as well as local publications, there are now a total of 65 countries that have one or more publications associated with the outcomes presented on the Polaris Observatory.  The supplement can be downloaded for free (Link)....
Read More

Only nine countries are on track to achieve elimination by 2030

According to the Polaris Observatory, only Iceland, Qatar, Australia, Georgia, Japan, Netherlands, Egypt, France, and Germany are on track to achieve the WHO HCV elimination targets by 2030. Of these, Iceland and Georgia are receiving their treatments for free from Gilead Sciences.  Most countries have not invested sufficiently in screening to diagnose those with HCV.  In addition, the average treatment rate remains well below 10%, which is required to reduce liver related deaths.  Also, many countries, including the United States, restrict treatment.  “With these barriers, we will not achieve the reduction in liver related deaths, diagnosed, and treatment targets in most countries in the world,” says Homie Razavi, the managing director at the CDA Foundation (Link)....
Read More

The CDA Foundation presented the global epidemiology of HCV at the World Health Summit in Berlin

The World Health Summit was first launched in 2009 to bring together stakeholders and decision-makers from all sectors of health and healthcare. This year’s summit, held October 14-16 in Berlin, attracted 2,000 participants from academia, industry, politics and civil society. On the last day of the summit, the CDA Foundation presented the 2016 Global and European figures for HCV epidemiology at an exclusive session on “Evidence as a Policy Driver, Towards HepC Elimination.” The session was organized by Ricardo Baptista Leite (Member of Parliament – Portugal, and Head of Public Health at the Catolica University) and chaired by Christian Busoi (Member of the European Parliament, Friends of the Liver Group). Speakers included Sarah Blach (CDA Foundation); Tatjana Reic (ELPA); Achim Kautz (Leberhilf Projekt gUG), Raoul Blindenbacher (the Graduate Institute, Geneva), and Ricardo Baptista Leite. The CDA Foundation slides presented at this session are available by request. ...
Read More

The World Hepatitis Summit is being held in Sao Paulo, Brazil

The World Hepatitis Summit will be held on November 1-3 in Sao Paulo, Brazil. At this meeting, the World Health Organization will present the results of the 2016 cascade of care developed by the CDA Foundation. In addition, representatives from the foundation will chair a session on access to drugs and diagnostics. There will be two presentations by the CDA Foundation: How modeling can be used to drive policy change, and, from economic analysis to financial dialogue. We will also be on a panel discussion on use of financing for hepatitis within a health systems approach. Finally, the foundation is co-sponsoring a luncheon of Friday, with the Zeshan Foundation, titled “Public private partnership to eliminate hepatitis and the role of the civil society”. We look forward to seeing all who are attending the summit....
Read More